Enrolling more participants from groups underrepresented in biomedical research is a laudable goal, but the current administration's policies may make it hard to achieve.
President Donald Trump's budget blueprint includes a nearly 20 percent cut for the National Institutes of Health.
In his report, President Trump called for a reduction in National Institutes of Health funding, along with a reorganization of the agency.
President Donald Trump taps Scott Gottlieb, an American Enterprise Institute fellow, to run the Food and Drug Administration.
In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."
A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.
Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.
A candidate to be President Donald Trump's science advisor supports limiting federal researchers' ability to discuss their findings, the Guardian reports.
Vox reports that recent policy shifts have led to confusion and uncertainty at the US Food and Drug Administration.
The Wall Street Journal reports that Rep. Tom Price, the pick to lead the Department of Health and Human Services, bought stock in a pharma firm at a special price.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.